终末期肝病合并细菌、真菌感染临床转归的无创指标OA
Non-invasive markers for prognosis of end-stage liver disease-associated bacterial and fungal infections
感染是终末期肝病患者常见的并发症,也是导致病情进展与死亡的关键因素.由于此类患者合并感染时临床表现往往不典型、病原学证据难以获取,因此能够辅助精准诊断、预测临床结局的无创指标显得尤为重要.临床常用的无创指标包括肝功能相关指标、炎症标志物、影像学检查、分子诊断技术以及各种临床评分系统等.临床医生需基于病情、结合诸多无创指标进行综合判断,以期实现终末期肝病合并感染患者的早期识别、及时准确的治疗,从而最终改善患者预后.
Infection is a common complication in patients with end-stage liver disease and a major contributor to disease progression and mortality.Since clinical manifestations in these patients are often atypical and etiological evidence is difficult to obtain,non-invasive markers that aid in accurate diagnosis and prediction of clinical outcomes are particularly important.Commonly used non-invasive indicators include liver function parameters,inflammatory markers,imaging examinations,molecular diagnostic techniques,and various clinical scoring systems.By integrating these markers with clinical findings,clinicians can achieve early detection and initiate timely and appropriate treatment for end-stage liver disease patients with infection,ultimately improving patient prognosis.
盛秋菊;王晓颖;丁洋
中国医科大学附属盛京医院感染科辽宁省病毒性肝炎重点实验室,辽宁沈阳 110022中国医科大学附属盛京医院感染科辽宁省病毒性肝炎重点实验室,辽宁沈阳 110022中国医科大学附属盛京医院感染科辽宁省病毒性肝炎重点实验室,辽宁沈阳 110022
医药卫生
终末期肝病细菌感染真菌感染临床转归无创指标
end-stage liver diseasebacterial infectionfungal infectionclinical outcomenon-invasive markers
《中国实用内科杂志》 2026 (2)
97-102,6
辽宁省科技计划联合计划(自然科学基金-面上项目)(2024-MSLH-570)
评论